These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 654420)

  • 1. [Antiarrhythmic effect of propafenone in relation to serum concentration and conduction time (author's transl)].
    Meyer-Estorf G; Keller K; Beck OA; Hochrein H
    Z Kardiol; 1978 May; 67(5):353-6. PubMed ID: 654420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
    Meyer-Estorf G; Keller K; Beck OA; Hochrein H
    Z Kardiol; 1980 Jun; 69(6):417-20. PubMed ID: 6160684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.
    Keller K; Meyer-Estorf G; Beck OA; Hochrein H
    Eur J Clin Pharmacol; 1978 Mar; 13(1):17-20. PubMed ID: 639829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment with the new antiarrhythmic drug propafenone in correlation to plasma levels (author's transl)].
    Wiebringhaus E; Seipel L; Breithardt G; Loogen F
    Z Kardiol; 1977 Nov; 66(11):625-32. PubMed ID: 22958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA; Campos Peris JV; García García J; Jaen Armand E; Ruiz Ros JA; Salas Nieto J; Rodríguez Ruiz P; Marco Quiles J; Martínez Jérez M; Pico Aracil F
    Arch Inst Cardiol Mex; 1981; 51(4):371-6. PubMed ID: 7337481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)].
    Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1261-5. PubMed ID: 78793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral therapy of ectopic cardiac arrhythmias with Propafenon (author's transl)].
    Beck OA; Abdulla S; Hochrein H
    Med Klin; 1975 Oct; 70(42):1713-6. PubMed ID: 52828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research].
    Beck OA; Spielmann H; Witt E; Oeff M; Liddard C; Hochrein H
    Arzneimittelforschung; 1980; 30(12):2172-81. PubMed ID: 7194081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS; Rieder L
    Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A; Schmuderer R; Hilpert P
    Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antiarrhythmia agents: propafenone and flecainide].
    Leclercq JF
    Presse Med; 1985 Mar; 14(12):685-9. PubMed ID: 3157964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.